Is a complete FRA/HHB0 research report available?

No complete published report is available for fra/HHB0 (FRA/HHB0) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

FRA/HHB0 (FRA/HHB0)

Frankfurt Stock Exchange: FRA/HHB0 · EUR

€2.40

+0.00 (0.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first FRA/HHB0 analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	5.6M
Net income (ttm)	-5.9M
EPS (ttm)	-€0.01
Volume	0

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -5.9M
EPS (ttm): -€0.01
Market cap: 5.6M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-07-31 02:00 UTC

All FRA/HHB0 indicators

Market & fundamental data

Available fields

141

Groups with data

Currency

USD

Showing 141 of 141 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Israel
Country code	DE
Employees	5
Employees Change	3%
Employees Change Percent	42.86
Enterprise value	EUR 5.5M
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-07-31
Market cap	EUR 5.6M
Price	EUR 2.4
Price currency	EUR
Sic	2836
Symbol	fra/HHB0
Website	https://www.xtlbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-106.47%
FCF yield	-15.94%
P/B ratio	-25.77x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	EUR -5.9M
Profit Per Employee	EUR -1.2M
ROA	-21.01
Roa5y	-12.86
ROCE	576.8
ROE	-29.3
Roe5y	-19.9
ROIC	-34.43

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-19.03%
Cagr15y	-17.16%
Cagr1y	-56.23%
Cagr3y	-4.55%
Cagr5y	-27.13%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	EUR 141,382
Cash	EUR 64,729
Current Assets	EUR 143,908
Current Liabilities	EUR 364,106
Debt	EUR 0
Equity	EUR -216,332
Interest Coverage	-209.3
Liabilities	EUR 357,714
Long Term Assets	EUR -2,526
Long Term Liabilities	EUR -6,392
Net Cash	EUR 64,729
Net Cash By Market Cap	EUR 1.16
Net Cash Growth	-92.44%
Tangible Book Value	EUR -216,332
Tangible Book Value Per Share	EUR -0

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.4
Net Working Capital	EUR -281,061
Quick ratio	0.18
Working Capital	EUR -216,332

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-52.32%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-87.89%
1Y total return	-56.2%
200-day SMA	2.5
3Y total return	-13.04%
50-day SMA	2.07
50-day SMA vs 200-day SMA	50under200
5Y total return	-79.45%
All Time High	630
All Time High Change	-99.62%
All Time High Date	2008-09-04
All Time Low	0.2
All Time Low Change	1,100%
All Time Low Date	2008-12-10
ATR	0.11
Ch YTD	14.29
High	2.4
High52	16
High52 Date	2025-10-08
High52ch	-85%
Low	2.4
Low52	1.59
Low52 Date	2026-06-08
Low52ch	50.94%
Ma50ch	16%
Price vs 200-day SMA	-3.96%
RSI	56.28
RSI Monthly	42.95
RSI Weekly	51.46
Sharpe ratio	0.51x
Sortino ratio	1.41
Total Return	-52.32%
Tr YTD	14.29
Tr15y	-94.06%
Tr1m	38.73%
Tr1w	1.7%
Tr3m	33.33%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -1.2M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	600,872,347%
Net Borrowing	180,318.9
Shares Insiders	38.87%
Shares Institutions	3.01%
Shares Yo Y	52.32%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -1.2M
Adjusted OCF	-1,188,544.6
Average Volume	15.65x
Bv Per Share	-0
Ch10y	-87.89
Ch15y	-94.06
Ch1m	38.73
Ch1w	1.7
Ch1y	-56.2
Ch3m	33.33
Ch3y	-13.04
Ch5y	-79.45
Ch6m	-13.67
Change	0%
Change From Open	0
Close	2.4
Days Gap	0
Depreciation Amortization	172,516.7
Earnings Date	2026-08-10
EBIT	EUR -1.2M
EBITDA	EUR -1.1M
EPS	EUR -0.01
F Score	1
FCF	EUR -888,591
FCF EV Yield	-16.14x
Financing CF	177,154
Fiscal Year End	December
Founded	1,993
Investing CF	444,587
Is Primary Listing	0
Last Earnings Date	2026-03-26
Last Report Date	2025-12-31
Last Split Date	2026-03-25
Last Split Type	Reverse
Ma150	2.27
Ma150ch	5.68%
Ma20	2.31
Ma20ch	4.08%
Net CF	-251,252
Next Earnings Date	2026-08-10
Open	2.4
Price Date	2026-07-30
Relative Volume	20x
Share Based Comp	294,688
Tr6m	-13.67%
Volume	0

FRA/HHB0 (FRA/HHB0)

Coverage state: Market snapshot only — no published research

Generate the first FRA/HHB0 analysis

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/HHB0

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FRA/HHB0 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on FRA/HHB0

Frequently asked questions